Skip to main content
. 2022 Dec 6;14:1463–1476. doi: 10.2147/CLEP.S391819

Table 5.

The SUCRA (%) Results of Network Meta of the 5 Outcome Indicators

Treatment Δ Weight(kg) Δ HbA1c (%) Total Adverse Events Serious Adverse Events Hypoglycemic Events
Placebo 0.0 0.0 4.1 23.1 41.8
Liraglutide 1.8mg 31.6 50.9 51.6 76.6 17.5
Liraglutide 3.0mg 74.7 / 75.1 76.7 70.8
Semaglutide 1.0mg 43.6 66.1 41.8 11.5 22.7
Semaglutide 2.4mg 100.0 83.0 77.3 62.0 97.2